Algeta's Alpharadin results even better than expected, analysis shows
13 February 2012
Gemma Sharman
Please Login to read the full article.
13 February 2012
Gemma Sharman
gemma.sharman@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Placebo patients to be offered Algeta's Alpharadin after efficacy in cancer trial
- Algeta shows off impressive Alpharadin Phase III data
- Exelixis pained by FDA SPA no-show but pushes ahead with cabozantinib
- US regulatory hurry-up brings Algeta's Alpharadin closer for prostate cancer
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
